Cited by 104Advanced Glycation End Products researchCancer, Hypoxia, and MetabolismPotato Plant Research

Methylglyoxal-derived stress: An emerging biological factor involved in the onset and progression of cancer

Bellahcène, Akeila, Nokin, Marie-Julie, Castronovo, Vincent, Schalkwijk, Casper·2018·Seminars in Cancer Biology

Abstract

Cancer is a disease characterised by uncontrolled growth and proliferation of cells. Tumours primarily show a higher rate of glucose uptake for lactate production even in the presence of functional mitochondria. An important metabolic consequence is intracellular formation of glucose-derived carbonyl reactive species such as methylglyoxal (MG). It has become clear that MG is the most potent glycation agent in our body, leading to alterations of proteins and DNA, and cellular dysfunction. In recent years, emerging evidence indicates that MG plays a role in the development of cancer. This review will examine studies regarding the effects of MG on cancer onset and progression and discuss their controversies. Finally, the utilisation of inhibitors and MG scavengers will be addressed in the context of MG-mediated stress blockade for cancer therapy.

Integrity signals

Registry

Crossref · 10.1016/j.semcancer.2017.05.010

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Methylglyoxal-mediated stress is involved in cancer progression and activates AKT signaling, suggesting that methylglyoxal scavengers may be more effective with AKT inhibitors in KRAS-mutant colorectal cancer cells.

    “Methylglyoxal-mediated stress was shown to be involved in cancer progression41 and to be a potent activator of AKT signaling, suggesting that utilizing methylglyoxal scavengers in KRAS mutant colorectal cancer cells might be more effective when combined with AKT inhibitors40.”

Cites

1 retracted

Flagged first, then by citations

2 of the 158 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Bellahcène, A., Nokin, M.-J., Castronovo, V., & Schalkwijk, C.
Affiliations
  • University of Liège (BE)
  • Maastricht University (NL)
Corresponding author
Bellahcène, Akeila
Venue
Seminars in Cancer Biology
Publisher
Elsevier BV
Published
2018-04
Volume
49
Pages
64-74
ISSN
1044-579X (ISSN-L)
OpenAlex
W2622101156
Cited by
98
References
158
Citations by year
2026: 7 · 2025: 8 · 2024: 13 · 2023: 18 · 2022: 13 · 2021: 12 · 2020: 9 · 2019: 14 · 2018: 2 · 2017: 2
FWCI
0.96
Type
journal article
Language
en
Open access
closed
Locations
  • Seminars in Cancer Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Research Publications (Maastricht University) (submittedVersion)
  • ORBi (University of Liège) (submittedVersion)
Funders
  • University of Liège
  • “Télévie-National Fund for Scientific Research”, Belgium
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Potato Plant Research
Keywords
methylglyoxal, carbonyl stress, cancer onset, tumor progression, glycation, glucose metabolism, lactic acid production, protein carbonylation, DNA damage, cancer therapy
MeSH terms
Animals, Antineoplastic Agents, Cell Transformation, Neoplastic, Glycolysis, Glycosylation, Humans, Lactoylglutathione Lyase, Pyruvaldehyde, Biomarkers, Tumor, Signal Transduction, Drug Resistance, Neoplasm, Gene Silencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review